Cancer survival prediction based on soft-label guided contrastive learning and global feature fusion
Huiying Jiang1, Wenlan Chen2, Fei Guo2
1School of Information Science and Engineering, Shandong Normal University, Jinan 250358, China.
Motivation:
The high complexity and heterogeneity of cancer pose significant challenges to personalized treatment, making the improvement of cancer survival prediction accuracy crucial for clinical decision-making. The integration of multi-omics data enables a more comprehensive capture of multi-layered information in complex biological processes. However, existing survival analysis models still face limitations in accurately extracting and effectively integrating the unique and shared information from multi-omics data.
Results:
In this article, we propose a novel prediction model for cancer survival based on soft-label guided contrastive learning and global feature fusion, namely SLCGF. Our model first extracts paired feature representations for each omics using Siamese encoders. We then perform intra-view and inter-view contrastive learning simultaneously, employing a neighborhood-based paradigm to enhance feature discrimination and alignment across omics. To ensure reliable neighbor retention and improve model robustness, we treat the affinities between samples and their high-order neighbors as soft labels to guide the contrastive learning process at both levels. In addition, we adopt a global self-attention mechanism to obtain the unified representation for cancer survival prediction, where the cross-omics connections are fully exploited and complementary information is adaptively integrated. We comprehensively evaluate the performance of our model on 13 cancer multi-omics datasets, and the experimental results demonstrate its superiority over existing approaches.
Availability And Implementation:
Source code is available at https://github.com/LiangSDNULab/SLCGF.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


